Pulmonx Corp Stock In The News

LUNG Stock  USD 7.52  0.47  6.67%   
Our overall analysis of Pulmonx Corp's news coverage and content from conventional and social sources shows investors' bearish mood towards Pulmonx Corp. The specific impact of Pulmonx Corp news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Pulmonx Corp's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Pulmonx Corp headlines in addition to utilizing other, more conventional financial analysis modules. Check out Pulmonx Corp Backtesting and Pulmonx Corp Hype Analysis.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.

Pulmonx Corp Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results
https://www.globenewswire.com/news-release/2025/02/19/3029141/0/en/Pulmonx-Reports-Record-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html
 Neutral
Macroaxis News: globenewswire.com
Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day
https://www.globenewswire.com/news-release/2025/02/13/3026276/0/en/Pulmonx-to-Present-at-the-Citi-2025-Unplugged-Medtech-and-Life-Sciences-Access-Day.html
 Neutral
Macroaxis News: globenewswire.com
Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
https://www.globenewswire.com/news-release/2025/02/05/3021579/0/en/Pulmonx-to-Report-Fourth-Quarter-and-Full-Year-2024-Financial-Results-on-February-19-2025.html
 Neutral
Yahoo News
Insider Sell: President and CEO French Glendon E. III Sells 10,000 Shares of Pulmonx Corp (LUNG)
https://finance.yahoo.com/news/insider-sell-president-ceo-french-041914838.html
 Neutral
Yahoo News
The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors
https://finance.yahoo.com/news/honest-company-announces-appointment-michael-140000709.html
 Bullish
Yahoo News
Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare
https://finance.yahoo.com/news/biotech-breakthroughs-3-revolutionary-stocks-180802568.html
 Bullish
Macroaxis News: globenewswire.com
Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
https://www.globenewswire.com/news-release/2023/11/15/2781407/0/en/Pulmonx-to-Present-at-the-Piper-Sandler-35th-Annual-Healthcare-Conference.html
 Neutral
Yahoo News
Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
https://finance.yahoo.com/news/pulmonx-present-piper-sandler-35th-210500749.html
 Neutral
Macroaxis News: globenewswire.com
Pulmonx to Participate at Upcoming Investor Conferences
https://www.globenewswire.com/news-release/2023/10/31/2770617/0/en/Pulmonx-to-Participate-at-Upcoming-Investor-Conferences.html
 Neutral
Yahoo News
Pulmonx to Participate at Upcoming Investor Conferences
https://finance.yahoo.com/news/pulmonx-participate-upcoming-investor-conferences-200500412.html
 Neutral

Pulmonx Corp Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Pulmonx and other traded companies coverage with news coverage. We help investors stay connected with Pulmonx headlines for the 16th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Pulmonx Stock performance. Please note that trading solely based on the Pulmonx Corp hype is not for everyone as timely availability and quick action are needed to avoid losses.
Pulmonx Corp's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Pulmonx Corp investors visualize upcoming and past events in order to time the market based on Pulmonx Corp noise-free hype analysis.
Pulmonx Corp stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Pulmonx earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Pulmonx Corp that are available to investors today. That information is available publicly through Pulmonx media outlets and privately through word of mouth or via Pulmonx internal channels. However, regardless of the origin, that massive amount of Pulmonx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pulmonx Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pulmonx Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pulmonx Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pulmonx Corp alpha.

Pulmonx Largest EPS Surprises

Earnings surprises can significantly impact Pulmonx Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-05-04
2021-03-31-0.38-0.340.0410 
2024-02-21
2023-12-31-0.41-0.360.0512 
2022-05-03
2022-03-31-0.37-0.43-0.0616 
2024-07-31
2024-06-30-0.43-0.350.0818 
2024-10-30
2024-09-30-0.45-0.360.0920 
2021-11-02
2021-09-30-0.37-0.280.0924 
View All Earnings Estimates

Pulmonx Corp Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Pulmonx Corp Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
news
11th of March 2025
Analyzing Spectral Medical Pulmonx
at thelincolnianonline.com 
Simply Wall St News at Macroaxis
7th of March 2025
Have Pulmonx Insiders Been Selling Stock
at simplywall.st 
Google News at Macroaxis
5th of March 2025
Disposition of 2017 shares by Geoffrey Rose of Pulmonx Corp at 7.12 subject to Rule 16b-3
at news.google.com 
Simply Wall St News at Macroaxis
28th of February 2025
Pulmonx Full Year 2024 Earnings Beats Expectations
at simplywall.st 
seekingalpha News
20th of February 2025
Pulmonx projects 16-18 percent constant currency growth for 2025 with key initiatives scal...
at seekingalpha.com 
Yahoo News
19th of February 2025
What To Expect From Pulmonx Corp Q4 2024 Earnings
at finance.yahoo.com 
news
13th of February 2025
Pulmonx Co. Receives Consensus Rating of Moderate Buy from Analysts
at thelincolnianonline.com 
Gurufocus Stories at Macroaxis
5th of February 2025
Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
at gurufocus.com 
Macroaxis News
23rd of December 2024
Acquisition by Geoffrey Rose of 69100 shares of Pulmonx Corp at 9.3 subject to Rule 16b-3
at MacroaxisInsider 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pulmonx Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pulmonx Corp's short interest history, or implied volatility extrapolated from Pulmonx Corp options trading.
When determining whether Pulmonx Corp is a strong investment it is important to analyze Pulmonx Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmonx Corp's future performance. For an informed investment choice regarding Pulmonx Stock, refer to the following important reports:
Check out Pulmonx Corp Backtesting and Pulmonx Corp Hype Analysis.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.44)
Revenue Per Share
2.142
Quarterly Revenue Growth
0.233
Return On Assets
(0.21)
Return On Equity
(0.55)
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.